Helix BioMedix, Inc. Chief Scientific Officer Stepping Down, Company Focuses on Commercialization of Peptide Pipeline
BOTHELL, Wash.--(BUSINESS WIRE)--Helix BioMedix, Inc. (OTCBB:HXBM), a developer of bioactive peptides, today announced that Dr. Timothy Falla will leave his post as Vice President and Chief Scientific Officer effective February 28, 2011. Dr. Falla will assist the company on a consulting basis in managing the Helix BioMedix patent portfolio during a transitional period.